| Symbol |
Name |
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC10
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 10
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ADAL
|
adenosine deaminase-like
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADCY3
|
adenylate cyclase 3
|
|
ADCY5
|
adenylate cyclase 5
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADSS
|
adenylosuccinate synthase
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
APC
|
adenomatous polyposis coli
|
|
APLN
|
apelin
|
|
APLNR
|
apelin receptor
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA2
|
apolipoprotein A-II
|
|
APOA5
|
apolipoprotein A-V
|
|
APOE
|
apolipoprotein E
|
|
APOL1
|
apolipoprotein L, 1
|
|
APOM
|
apolipoprotein M
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARRB2
|
arrestin, beta 2
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
|
ATXN2
|
ataxin 2
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
BAG1
|
BCL2-associated athanogene
|
|
BASP1
|
brain abundant, membrane attached signal protein 1
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL9
|
B-cell CLL/lymphoma 9
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BHMT
|
betaine--homocysteine S-methyltransferase
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BPIFA1
|
BPI fold containing family A, member 1
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRAP
|
BRCA1 associated protein
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BTBD9
|
BTB (POZ) domain containing 9
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
C1GALT1
|
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C3
|
complement component 3
|
|
C5
|
complement component 5
|
|
CA9
|
carbonic anhydrase IX
|
|
CABIN1
|
calcineurin binding protein 1
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CALR
|
calreticulin
|
|
CAPN10
|
calpain 10
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD1D
|
CD1d molecule
|
|
CD28
|
CD28 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD80
|
CD80 molecule
|
|
CD81
|
CD81 molecule
|
|
CD86
|
CD86 molecule
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFP
|
complement factor properdin
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHRNA6
|
cholinergic receptor, nicotinic, alpha 6 (neuronal)
|
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal)
|
|
CISH
|
cytokine inducible SH2-containing protein
|
|
CLASP1
|
cytoplasmic linker associated protein 1
|
|
CLDN1
|
claudin 1
|
|
CLDN3
|
claudin 3
|
|
CLDN5
|
claudin 5
|
|
CLU
|
clusterin
|
|
CNDP1
|
carnosine dipeptidase 1 (metallopeptidase M20 family)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTNAP5
|
contactin associated protein-like 5
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPA1
|
carboxypeptidase A1 (pancreatic)
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBL1
|
catenin, beta like 1
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTTN
|
cortactin
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DCC
|
DCC netrin 1 receptor
|
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DEPDC1B
|
DEP domain containing 1B
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DNM1
|
dynamin 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ELMO1
|
engulfment and cell motility 1
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
ENPP4
|
ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative)
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPO
|
erythropoietin
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERLIN2
|
ER lipid raft associated 2
|
|
ESR1
|
estrogen receptor 1
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
FAM175A
|
family with sequence similarity 175, member A
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FCRL3
|
Fc receptor-like 3
|
|
FDPS
|
farnesyl diphosphate synthase
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGB
|
fibrinogen beta chain
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FGGY
|
FGGY carbohydrate kinase domain containing
|
|
FH
|
fumarate hydratase
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FN1
|
fibronectin 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXO1
|
forkhead box O1
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FRZB
|
frizzled-related protein
|
|
FTO
|
fat mass and obesity associated
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GABRA5
|
gamma-aminobutyric acid (GABA) A receptor, alpha 5
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GATA2
|
GATA binding protein 2
|
|
GBA
|
glucosidase, beta, acid
|
|
GGPS1
|
geranylgeranyl diphosphate synthase 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GLIS3
|
GLIS family zinc finger 3
|
|
GLO1
|
glyoxalase I
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GMIP
|
GEM interacting protein
|
|
GNB1
|
guanine nucleotide binding protein (G protein), beta polypeptide 1
|
|
GNB2
|
guanine nucleotide binding protein (G protein), beta polypeptide 2
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GPC5
|
glypican 5
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GRM4
|
glutamate receptor, metabotropic 4
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBE1
|
hemoglobin, epsilon 1
|
|
HCRTR1
|
hypocretin (orexin) receptor 1
|
|
HFE
|
hemochromatosis
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMCN1
|
hemicentin 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOXA9
|
homeobox A9
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HYMAI
|
hydatidiform mole associated and imprinted (non-protein coding)
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNG
|
interferon, gamma
|
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGHMBP2
|
immunoglobulin mu binding protein 2
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL13
|
interleukin 13
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL23R
|
interleukin 23 receptor
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL3
|
interleukin 3
|
|
IL36RN
|
interleukin 36 receptor antagonist
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
INS
|
insulin
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRAK3
|
interleukin-1 receptor-associated kinase 3
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRGM
|
immunity-related GTPase family, M
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNN3
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3
|
|
KIF11
|
kinesin family member 11
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LAMA3
|
laminin, alpha 3
|
|
LAMB3
|
laminin, beta 3
|
|
LAMC2
|
laminin, gamma 2
|
|
LARGE
|
like-glycosyltransferase
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LOX
|
lysyl oxidase
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LOXL3
|
lysyl oxidase-like 3
|
|
LOXL4
|
lysyl oxidase-like 4
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPL
|
lipoprotein lipase
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LTA
|
lymphotoxin alpha
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
LTC4S
|
leukotriene C4 synthase
|
|
LY96
|
lymphocyte antigen 96
|
|
MAD1L1
|
MAD1 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MADD
|
MAP-kinase activating death domain
|
|
MALT1
|
MALT1 paracaspase
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K5
|
mitogen-activated protein kinase kinase 5
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC4R
|
melanocortin 4 receptor
|
|
MC5R
|
melanocortin 5 receptor
|
|
MCF2L2
|
MCF.2 cell line derived transforming sequence-like 2
|
|
MCHR1
|
melanin-concentrating hormone receptor 1
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDGA1
|
MAM domain containing glycosylphosphatidylinositol anchor 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEIS1
|
Meis homeobox 1
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR125B2
|
microRNA 125b-2
|
|
MIR137
|
microRNA 137
|
|
MIR146A
|
microRNA 146a
|
|
MIR149
|
microRNA 149
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR222
|
microRNA 222
|
|
MIR23B
|
microRNA 23b
|
|
MIR499A
|
microRNA 499a
|
|
MIR98
|
microRNA 98
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP15
|
matrix metallopeptidase 15 (membrane-inserted)
|
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP21
|
matrix metallopeptidase 21
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MOBP
|
myelin-associated oligodendrocyte basic protein
|
|
MORF4L1
|
mortality factor 4 like 1
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MSH2
|
mutS homolog 2
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MT-ND3
|
NADH dehydrogenase, subunit 3 (complex I)
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC13
|
mucin 13, cell surface associated
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MUTYH
|
mutY homolog
|
|
MVP
|
major vault protein
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYLK
|
myosin light chain kinase
|
|
MYO1A
|
myosin IA
|
|
NAIP
|
NLR family, apoptosis inhibitory protein
|
|
NANOG
|
Nanog homeobox
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOA7
|
nuclear receptor coactivator 7
|
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
|
|
NGB
|
neuroglobin
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRG1
|
neuregulin 1
|
|
NRP1
|
neuropilin 1
|
|
NRXN1
|
neurexin 1
|
|
NTNG1
|
netrin G1
|
|
NTNG2
|
netrin G2
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa
|
|
OCA2
|
oculocutaneous albinism II
|
|
OCLN
|
occludin
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OXTR
|
oxytocin receptor
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PAM
|
peptidylglycine alpha-amidating monooxygenase
|
|
PARK16
|
Parkinson disease 16 (susceptibility)
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD6IP
|
programmed cell death 6 interacting protein
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PDZK1IP1
|
PDZK1 interacting protein 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PGR
|
progesterone receptor
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PITX3
|
paired-like homeodomain 3
|
|
PKLR
|
pyruvate kinase, liver and RBC
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAGL1
|
pleiomorphic adenoma gene-like 1
|
|
PLCB2
|
phospholipase C, beta 2
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLG
|
plasminogen
|
|
PLOD1
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1
|
|
PLP1
|
proteolipid protein 1
|
|
PML
|
promyelocytic leukemia
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPAP2B
|
phosphatidic acid phosphatase type 2B
|
|
PPAP2C
|
phosphatidic acid phosphatase type 2C
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP6C
|
protein phosphatase 6, catalytic subunit
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRMT7
|
protein arginine methyltransferase 7
|
|
PRNP
|
prion protein
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PSG11
|
pregnancy specific beta-1-glycoprotein 11
|
|
PSMB5
|
proteasome (prosome, macropain) subunit, beta type, 5
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRS
|
protein tyrosine phosphatase, receptor type, S
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAD51
|
RAD51 recombinase
|
|
RAD51B
|
RAD51 paralog B
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RANBP9
|
RAN binding protein 9
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RETN
|
resistin
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RHOA
|
ras homolog family member A
|
|
RNASE7
|
ribonuclease, RNase A family, 7
|
|
RORA
|
RAR-related orphan receptor A
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RTKN
|
rhotekin
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100P
|
S100 calcium binding protein P
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
|
SELE
|
selectin E
|
|
SEPT12
|
septin 12
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
|
SFTPA1
|
surfactant protein A1
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC18A1
|
solute carrier family 18 (vesicular monoamine transporter), member 1
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A10
|
solute carrier family 2 (facilitated glucose transporter), member 10
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRI
|
sorcin
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STK10
|
serine/threonine kinase 10
|
|
STK11
|
serine/threonine kinase 11
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBX1
|
T-box 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
THEMIS2
|
thymocyte selection associated family member 2
|
|
TIMELESS
|
timeless circadian clock
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TMEM127
|
transmembrane protein 127
|
|
TMEM18
|
transmembrane protein 18
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP1MT
|
topoisomerase (DNA) I, mitochondrial
|
|
TOPBP1
|
topoisomerase (DNA) II binding protein 1
|
|
TP53
|
tumor protein p53
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRB
|
T cell receptor beta locus
|
|
TRD
|
T cell receptor delta locus
|
|
TREX1
|
three prime repair exonuclease 1
|
|
TRIM56
|
tripartite motif containing 56
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TRPM6
|
transient receptor potential cation channel, subfamily M, member 6
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
TYRO3
|
TYRO3 protein tyrosine kinase
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UIMC1
|
ubiquitin interaction motif containing 1
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WT1
|
Wilms tumor 1
|
|
XAF1
|
XIAP associated factor 1
|
|
XBP1
|
X-box binding protein 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC2
|
X-ray repair complementing defective repair in Chinese hamster cells 2
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XYLT1
|
xylosyltransferase I
|
|
ZNF804A
|
zinc finger protein 804A
|
|
ZNRD1
|
zinc ribbon domain containing 1
|
